June 20, 2019
HIV patients demonstrated greater adherence to their antiretroviral therapy (ART) following the use of a low-cost educational VR application, according to a new study published in the Interactive Journal of Medical Research.
Delivered in English and Spanish on a Dell Windows Mixed Reality headset, the seven-minute experience consisted of an interactive look at the cells and pathogens of a virtual...
May 29, 2019
Pillo Health, maker of conversational devices and platforms for medication adherence, has closed a $11 million Series A round led by Stanley Black & Decker’s Stanley Ventures with “significant participation” from Samsung Ventures. Existing backers BioAdvance, Hikma Ventures, Hackensack Meridien Health System’s Innovation Center Fund and Civilization Ventures also took part in the funding....
May 9, 2019
Transplant clinics in Sweden will see digital health startup Pilloxa’s innovation be deployed in a new collaboration with Novartis division Sandoz Nordics to improve medication adherence, announced today.
Founded in 2015, Pilloxa has developed a platform that consists of an intelligent pillbox, an app and a cloud solution, along with data driven services, that aims to help patients take their...
April 25, 2019
Diplomat Pharmacy has released some data about its partnership with smart pill bottle maker AdhereTech as the companies also announced plans to expand that deal.
The data, representative of more than 1,000 patients, shows that on average, patients who used the technology filled their medication one additional time over the course of the year. Patient retention was 12% higher, and the average...
January 17, 2019
Earlier today, Johnson & Johnson announced plans for a multi-year research program it will be launching with Apple to explore the role Apple Watches could play in senior health monitoring.
Set to kickoff later this year, the pragmatic randomized controlled trial study will be conducted in the US and enroll adults aged 65 years or older, according to a statement. Specifically, the primary...
December 7, 2018
When Mango Health announced last month that CEO Jason Oberfest was stepping down, the company didn't mention where Oberfest was going. Now, according to his LinkedIn, first spotted by CNBC, he has joined Apple's health team in an unspecified role.
Mango Health, which launched in 2012, has achieved success, or at least longetivity, as a gameified, incentive-based medication adherence app. He's...
December 5, 2018
Smart pill bottle cap maker Pillsy has launched a subsidiary that will pair the adherence technology with a nutritional supplement subscription service.
Called Stride Nutrition, the service is now available for consumers in the US with plans to expand internationally in 2019.
At launch, Stride’s service will have consumers sign up for one of three different supplement combinations: a multivitamin...
December 4, 2018
Pillo, the countertop device that uses conversational artificial intelligence to help patients manage their treatments, is now available to consumers for online purchase, manufacturer Pillo Health announced this morning. The device is currently being sold for $499 alongside a one-year subscription to the company’s connected service.
Designed for older patients or those with chronic diseases and...
November 1, 2018
Chronic disease management startup Livongo announced a handful of new offerings and partnerships this week, all organized around the theme of “Applied Health Signals,” a framework for thinking about the technologies and capabilities Livongo offers.
“Health Signals is really an enabling technology,” Amar Kendale, Livongo’s chief product officer, told MobiHealthNews. “Something that is part of all...
November 1, 2018
AdhereTech, a seven-year-old digital health startup focused on smart pill bottles and medication adherence, has raised a round of growth equity funding, its first since 2014. The company didn’t disclose the amount of the investment, which came from New York-based Argentum.
The company has deals with six top 30 pharma companies and all the major specialty pharmas, CEO Josh Stein told...